SCHEMBL6539601

SCHEMBL6539601

Cc1c(C(=O)Nc2ccc(C[C@@H](CO)N(C[C@H](O)COc3ccccc3)C(=O)O)cc2)cnn1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.54
NPC1 O15118 11/20 0.54
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
PKM P14618 3/20 0.52
POLB P06746 1/20 0.46
MET P08581 1/20 0.44
AXL P30530 1/20 0.44
NAMPT P43490 1/20 0.44
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
ALDH1A1 P00352 1/20 0.43
ADRB1 P08588 2/20 0.42
ADRB3 P13945 2/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6540012 0.83 ADRB1 (0.62) RAB9ANPC1HPGDSMN1; SMN2NFKB1
SCHEMBL6538630 0.79 ADRB1 (0.43) POLBMAPTADRB1ADRB3
SCHEMBL6539444 0.79 KMT2A (0.52) ALDH1A1ADRB1ADRB3
SCHEMBL6539311 0.79 ADRB1 (0.45) MAPTADRB1ADRB3
SCHEMBL6539459 0.78 NPC1 (0.46) RAB9ANPC1POLBALDH1A1ADRB1
SCHEMBL6539620 0.77 ADRB1 (0.46) RAB9ANPC1MAPTADRB1ADRB3
SCHEMBL6538847 0.77 ADRB1 (0.48) RAB9ANPC1MAPTADRB1ADRB3
SCHEMBL6539710 0.77 ADRB1 (0.53) RAB9ANPC1MAPTADRB1ADRB3
SCHEMBL6538911 0.76 ADRB3 (0.56) RAB9ANPC1POLBMAPTADRB1
SCHEMBL6539156 0.75 ADRB1 (0.53) MAPTADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed